About GenesisCare
GenesisCare is a Healthcare company based in Sydney (Australia) founded in 2004. A chain of multi-speciality clinics is operated in Australia. It operates on a Managed Services and HealthTech model. GenesisCare has raised $273.24 million across 2 funding rounds from investors including KKR, Macquarie Group and China Resources. GenesisCare has completed 3 acquisitions, including 21st Century Oncology, Cancer Partners UK and Oncosurgrupo. Its website genesiscare.com draws about 64 thousand monthly visits. Its Indian entity Genesis Hospital Private Limited reported revenue of ₹4.82 Cr. GenesisCare offers products and services including Radiation Therapy, Medical Oncology, Theranostics, and Benign Treatment Services. Its focus areas include Oncology and Cancer Treatment Services. Its competitors include On Point Skin Cancer Clinic, Mole Patrol and Genesis Cancer Care Western Australia.
Company details
GenesisCare is established as a leading cancer care provider in Australia, specializing in radiation therapy with an expanding presence in medical oncology, theranostics, and personalized medicine. Services are delivered across more than 50 locations nationwide, catering to over 30,000 patients annually. Modern treatment techniques and technologies are integrated to enhance patient care. A dedicated research team collaborates globally to introduce clinical innovations, ensuring that the latest advancements are accessible to patients close to home. Compassionate and contemporary care is provided by a team of 250 specialist doctors and experienced professionals.
- Headquarters Sydney, Australia
- SectorsHealthcare
- Phone•••• ••••
- Website genesiscare.com/au
- Social LinkedIn X Facebook Instagram
- Legal Name Genesiscare
- Date of Incorporation 25 Mar, 2009
- Indian entity revenue₹4.82 Cr
FY 2025 · -25% YoY
- Indian entity net loss-₹88.6 Lakh
FY 2025 · -18% margin
- Indian entity EBITDA-₹82.7 Lakh
FY 2025 · -17% margin
- Total Equity Funding$273.24M (USD)
in 2 rounds
- InvestorsKKR
& 3 more
- Investments & Acquisitions21st Century Oncology
& 2 more
Associated legal entities of GenesisCare
GenesisCare operates through Genesis Hospital Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genesis Hospital Private Limited CIN U85100DL2009PTC188823 | Active | 25 Mar 2009 | New Delhi, Delhi | ₹4.8 Cr | 5 | 2 | View details |
Products & Services of GenesisCare
GenesisCare offers a comprehensive portfolio of products and services, including Radiation Therapy, Medical Oncology, Theranostics, and Benign Treatment Services.
Radiation therapy is provided for various cancer types.
Medical oncology services are offered for cancer management.
Theranostics is utilized for personalized cancer treatment approaches.
Benign conditions are treated with specialized medical services.
Funding Insights of GenesisCare
GenesisCare has successfully raised a total of $273.24M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $273.24M
- Total Rounds 2
- First Round $273.24M
(Oct 2018)
- Investors Count 4
All 2 funding rounds of GenesisCare with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | Debt – Conventional | – | – | ||
| Oct 2018 | $273.24M | Series D | – | KKR, China Resources | – |
4 investors in total: 4 institutional.
Investors in GenesisCare
GenesisCare has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include KKR, Macquarie Group and China Resources.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are invested in by this private equity firm. | 1976 | kkr.com | New York, United States | |
Private equity investment firm focused on buyouts | alpinvest.com | Amsterdam, Netherlands | ||
| crc.com.hk | ||||
A global financial services organization with Australian heritage is operated. | 1969 | macquarie.com | Sydney, Australia |
Investor details for GenesisCare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Genesis Hospital Private Limited (GenesisCare)
Genesis Hospital Private Limited is the primary company behind GenesisCare. The board of Genesis Hospital Private Limited currently have 2 directors; the longest-serving is Sudesh Gupta, appointed in 2023. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sudesh Gupta DIN 10057122 | Director | 27 Feb 2023 | 3 yrs 8 mo | Genesis Hospital Private Limited |
| Shobhit Gupta DIN 10682934 | Additional Director | 07 Aug 2024 | 2 yrs 3 mo | Genesis Hospital Private Limited |
People of GenesisCare
10 people are tracked at GenesisCare (1 in leadership, 9 in board & advisors).
| Name | Role | Group |
|---|---|---|
Michael Guiney | Chair & Oncologist Director | Leadership |
Tim Tianwei Zhang | Investor Director, APH | Board & advisors |
Alan Carr | Investor Director, KKR | Board & advisors |
David Lang | Investor Director, KKR | Board & advisors |
Kerry Zhang | Investor Director, APH | Board & advisors |
Eric Rosenbach | Director | Board & advisors |
Simon McGrath | Director | Board & advisors |
Dennis Choi | Investor Director, APH | Board & advisors |
Gareth Woodbridge | Independent Director | Board & advisors |
Yawen Wu | Investor Director, APH | Board & advisors |
Complete people profiles for GenesisCare
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of GenesisCare
Figures of Genesis Hospital Private Limited, the primary company behind GenesisCare, for FY 2025. Revenue was ₹4.82 Cr (-25% year on year). Net loss was -₹88.6 Lakh (-18% margin). EBITDA was -₹82.7 Lakh (-17% margin). Revenue has grown at a compounded annual rate of -18% over three years and -13% over five years.
- ₹4.82 CrRevenue · FY 2025 · -25% YoY
- -₹88.6 LakhNet loss · -18% margin
- -₹82.7 LakhEBITDA · -17% margin
- ₹1 LakhPaid-up capital
- 5Employees (provident fund records)
- -18%Revenue CAGR, 3 years
- -13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Genesis Hospital Private Limited are on its company page.
Detailed financial statements for GenesisCare
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GenesisCare
GenesisCare has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include 21st Century Oncology, Cancer Partners UK and Oncosurgrupo.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cancer care is provided through a network of specialized hospitals. | 21co.com | Fort Myers, United States | 1982 | Dec 2019 | $1.1B | |
| oncosurgrupo.es | Spain | 0 | Sep 2016 | •••• | ||
Cancer care is provided through a chain of specialized centers. | cancerpartnersuk.org | United Kingdom | 2006 | Jul 2015 | •••• |
Complete acquisition details for GenesisCare
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of GenesisCare
6 dated milestones of GenesisCare across 15 years, from founding to its latest funding, stage changes and deals.
- Founded GenesisCare is founded.
- Acquisition Acquires Cancer Partners UK.
- Acquisition Acquires Oncosurgrupo.
- Funding First funding round of $273.2M.
- Funding Latest funding round, Debt – Conventional,.
- Acquisition Acquires 21st Century Oncology.
Competitors of GenesisCare
GenesisCare has 3 listed competitors in our database. They include On Point Skin Cancer Clinic, Mole Patrol and Genesis Cancer Care Western Australia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| onpointclinic.com.au | 2019 | Kangaroo Point, Australia | Offers skin cancer detection, diagnosis, and treatment through medical consultations and procedures. | |||
| molepatrol.com.au | 2018 | Perth, Australia | Provides skin cancer screening, biopsies, and treatments across clinics. | |||
| genesiscancercarewa.com.au | 1970 | Perth, Australia | Offers cancer treatment services including radiation and medical oncology in Australia. |
Detailed competitors of GenesisCare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GenesisCare
The website of GenesisCare (genesiscare.com) receives about 63.7K visits a month.
- Monthly visits63.7K
▼ 13% vs previous month
Websites whose visitors overlap most with GenesisCare. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| geth.es | 100% | 8.6K | #2,614,457 | View details | |
| matchtrial.health | 89% | 28.2K | #1,074,561 | View details | |
anzctr.org.au | anzctr.org.au | 89% | #513,921 | – | |
targetingcancer.com.au | targetingcancer.com.au | 86% | #2,407,966 | – | |
thancguide.org | thancguide.org | 84% | #653,348 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for GenesisCare
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genesiscare
Complete news archive for GenesisCare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenesisCare
GenesisCare was founded in 2004 and raised its 1st funding round 14 years after it was founded.
GenesisCare is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
GenesisCare is a funded company, having raised a total of $273.24M across 2 funding rounds to date. The company's 1st funding round was a Series D of $273.24M, raised on Oct 2018.
The primary company behind GenesisCare, Genesis Hospital Private Limited, reported revenue of ₹4.82 Cr for FY 2025, down 25% year on year.
GenesisCare is established as a leading cancer care provider in Australia, specializing in radiation therapy with an expanding presence in medical oncology, theranostics, and personalized medicine. Services are delivered across more than 50 locations nationwide, catering to over 30,000 patients annually. Modern treatment techniques and technologies are integrated to enhance patient care. A dedicated research team collaborates globally to introduce clinical innovations, ensuring that the latest advancements are accessible to patients close to home. Compassionate and contemporary care is provided by a team of 250 specialist doctors and experienced professionals.
GenesisCare's top competitors include On Point Skin Cancer Clinic, Mole Patrol and Genesis Cancer Care Western Australia.
GenesisCare offers Radiation Therapy, Medical Oncology, Theranostics, and Benign Treatment Services.
GenesisCare has made 3 acquisitions, including 21st Century Oncology, Cancer Partners UK, and Oncosurgrupo.
GenesisCare has 4 investors. Key investors include KKR, Macquarie Group, China Resources, and AlpInvest Partners.
GenesisCare operates through Genesis Hospital Private Limited.
The legal entities of GenesisCare currently have 2 directors, including Sudesh Gupta, Shobhit Gupta.